Market Tracker

12/06 6:51am ET

Depomed Inc (NASDAQ:DEPO)

19.53
Delayed Data
As of Dec 05
 +0.59 / +3.12%
Today’s Change
12.25
Today|||52-Week Range
27.02
+7.72%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close18.94
Today’s open18.89
Day’s range18.61 - 19.75
Volume1,097,108
Average volume (3 months)1,580,854
Market cap$1.2B
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+51.47%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...+2.70+3.59%
ALDRAlder Biopharmaceuti...+0.55+2.41%
XNCRXencor Inc+0.29+1.11%
PCRXPacira Pharmaceutica...+0.60+1.98%
Data as of 12/05/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts